Publications of U. Reichl
All genres
Poster (338)
2003
Poster
Hundt, B., Reichl, U., & Serum-free cultivation of CEF for vaccine production in microcarrier-systemsPresented at: 18th ESACT MeetingGranada, Spain, May 11, 2003.
Poster
Möhler, L., Bock, A., Sann, H., & Reichl, U.Mathematical Modeling of MDCK Cell Growth by the Use of On-line DataPresented at: DECHEMA Jahrestagung der BiotechnologenMunich, Germany, April 2, 2003.
Poster
Sann, H., Bock, A., & Reichl, U.Investigation of a new, sterile, deadvolume free sampling-system for universal applications, automated and suitable for online-analyzingPresented at: DECHEMA Jahrestagung der BiotechnologenMunich, Germany, April 2, 2003.
Poster
Schmidt, J. K., , & Reichl, U.Cooperation and competition: studies on heterogeneous microbial culturesPresented at: Jahrestagung der Vereinigung für allgemeine und angewandte Mikrobiologie (VAAM)Berlin, Germany, March 23, 2003.
Poster
Sann, H., & Reichl, U.Structured model of Influenza virus replication in MDCK cellsPresented at: 11th Congress on biotechnologyBasel, Switzerland, August 24, 2003.
, 2002
Poster
Genzel, Y. & Reichl, U.Analysis of cell growth, virus replication and medium composition in equine influenza vaccine productionPresented at: IUMS 2002Paris, France, July 27, 2002.
Poster
Genzel, Y. & Reichl, U.Analysis of cell growth, virus replication and medium composition in equine influenza vaccine productionPresented at: GVC/Dechema Jahrestagungen 2002Wiesbaden, Germany, June 11, 2002.
2001
Poster
Genzel, Y., , & Reichl, U.Development of bioprocess concepts on vaccine production: influenza virus as an examplePresented at: 17th ESACT MeetingTyloesand, Sweden, June 10, 2001.
Issue (1)
2015
Issue
Reichl, U. (Eds.) (2015)Vaccine BiotechnologyBiotechnology Journal, 10 (5)doi: 10.1002/biot.201590010.
& Editorial (2)
2021
Editorial
Rapp, E. & Reichl, U. (2021)Preface to Advances in GlycobiotechnologyAdvances in Glycobiotechnology, i-vi.
2015
Editorial
Reichl, U. (2015)Can modern vaccine technology pursue the success of traditional vaccine manufacturing?Biotechnology Journal, 10(5), 657–658WILEY-VCH Verlag GmbH & Co. KGaA, Weinheimdoi: 10.1002/biot.201500184.
& Patent (3)
2020
Patent
Kupke, S. Y., , Zmora, P., & Reichl, U. (2020)Protective Interfering Nucleic Acid Molecule And Virus - Like Particle, Virsl Vector, or Virus Particle Containing the same as well as Pharmaceutical Composition Containing the Protective Interfering Nucleic Acid and its use.
2019
Patent
Tapia, F., Genzel, Y., & Reichl, U. (2019)Plug Flow Tubular Bioreactor , System Containing the same and Method for Production of Virus.
Patent
Wolff, M. W., Pieler, M., Reichl, U., & Marichal-Gallardo, P. (2019)Method for the Separation of Virus Compositions Including Depletion and Purification thereof.
Preprint (5)
2024
Preprint
Hellwig, P., , , Reichl, U., & Benndorf, D. (2024)Detection, isolation and characterisation of phage-host complexes using BONCAT and click chemistrybioRxivdoi: 10.1101/2024.02.13.580147.
Preprint
Cajic, S., , , , , , Reichl, U., , Rapp, E., , & (2024)Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivitybioRxivdoi: 10.1101/2024.01.02.572735.
, , 2021
Preprint
Pelz, L., Rüdiger, D., , Genzel, Y., , Kupke, S. Y., & Reichl, U. (2021)Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapybioRxivdoi: 10.1101/2021.02.08.430251 .
Preprint
Pelz, L., , Reichl, U., , , , , & (2021)Interferon induction and not replication interference mainly determines anti-influenza virus activity of defective interfering particlesbioRxivdoi: 10.1101/2021.09.20.461172 .
, , , ,
Preprint
Benndorf, D., , , , , , , , , , , , , , , , , , , , , , Reichl, U., , , , , , , , , , , , , & (2021)Critical Assessment of Metaproteome Investigation (CAMPI): A Multi-Lab Comparison of Established WorkflowsbioRxivdoi: 10.1101/2021.03.05.433915 .
, , , , , , , ,